fibrinogen has been researched along with Cachexia in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (6.67) | 18.7374 |
1990's | 5 (33.33) | 18.2507 |
2000's | 6 (40.00) | 29.6817 |
2010's | 3 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, JD; Chen, VM; Curnow, JL; Ehteda, A; Kritharides, L; Reddel, CJ; Robertson, G; Taylor, R | 1 |
Fleet, M; Fritz, A; Komaragiri, R; Osman, F | 1 |
Gullett, N; Johnstone, PA; Kucuk, O; Rossi, P | 1 |
Ceylan, E; Cildag, O; Gulen, ST; Karadag, F; Karul, AB; Kilicarslan, N; Kuman, NK | 1 |
MacNee, W | 1 |
Barber, MD; Fearon, KC; McMillan, DC; Preston, T; Ross, JA; Slater, C | 1 |
Rubin, H | 1 |
Clark, AL; Ford, SJ; Parker, JD; Preston, T; Witte, KK | 1 |
Creutzberg, EC; Dentener, MA; Mercken, E; Pennings, HJ; Rijkers, GT; Wouters, EF | 1 |
Fong, M; Neta, R; Strassmann, G; Windsor, S | 1 |
Falconer, JS; Fearon, KC; McMillan, DC; Preston, T; Shenkin, A; Slater, C | 1 |
Barber, MD; Falconer, JS; Fearon, KC; McMillan, DC; Preston, T; Ross, JA | 1 |
Binz, JG; Brown, HR; Gaskill, BA; Lancaster, ME; Lenhard, JM; Lightfoot, RM; Paulik, MA; Sundseth, SS; Weiel, JE | 1 |
Mayer, G; Schomerus, H | 1 |
Eda, H; Horii, I; Ishikawa, T; Ishitsuka, H; Kataoka, T; Taguchi, T; Tanaka, T; Tanaka, Y; Udagawa, T | 1 |
5 review(s) available for fibrinogen and Cachexia
Article | Year |
---|---|
Protein catabolism in advanced renal disease: role of cytokines.
Topics: Albumins; Amino Acids; Cachexia; Cytokines; Energy Metabolism; Fibrinogen; Humans; Kidney Failure, Chronic; Malnutrition; Muscle Proteins; Renal Dialysis | 2008 |
Cancer-induced cachexia: a guide for the oncologist.
Topics: Acute-Phase Reaction; Anti-Inflammatory Agents, Non-Steroidal; Appetite Stimulants; C-Reactive Protein; Cachexia; Diagnosis, Differential; Dronabinol; Fibrinogen; Humans; Lipolysis; Medical Oncology; Muscle Proteins; Neoplasms; Psychotropic Drugs; Starvation; Syndrome; Tumor Necrosis Factor-alpha | 2009 |
Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease.
Topics: Adiponectin; Aging; Airway Remodeling; Biomarkers; C-Reactive Protein; Cachexia; Cardiovascular Diseases; CD40 Ligand; Chemokines, CC; Cytokines; Desmosine; Fibrinogen; Humans; Inflammation; Intercellular Adhesion Molecule-1; Isodesmosine; Lung Neoplasms; Matrix Metalloproteinases; Natriuretic Peptide, Brain; Osteoprotegerin; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Serum Amyloid A Protein; Severity of Illness Index; Telomere; Uteroglobin | 2013 |
Systemic effects of cancer: role of multiple proteases and their toxic peptide products.
Topics: Adipose Tissue; Animals; Cachexia; Cathepsins; Enzyme Activation; Fibrinogen; Humans; Immune Tolerance; Lipolysis; Neoplasms; Peptide Hydrolases; Peptides | 2005 |
Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia.
Topics: Acute-Phase Proteins; Acute-Phase Reaction; Amino Acids; Anorexia; Cachexia; Cytokines; Fibrinogen; Humans; Inflammation Mediators; Liver; Metabolic Diseases; Muscle, Skeletal; Nitrogen; Pancreatic Neoplasms; Protein Biosynthesis; Serum Albumin; Survival Rate; Weight Loss | 1999 |
2 trial(s) available for fibrinogen and Cachexia
Article | Year |
---|---|
Modulation of the liver export protein synthetic response to feeding by an n-3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patients.
Topics: Aged; Albumins; Cachexia; Chi-Square Distribution; Dietary Supplements; Fasting; Fatty Acids, Omega-3; Female; Fibrinogen; Humans; Liver; Male; Middle Aged; Nitrogen; Pancreatic Neoplasms; Phenylalanine; Statistics, Nonparametric | 2004 |
Effect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot study.
Topics: Acute-Phase Proteins; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Monoclonal; Biomarkers; C-Reactive Protein; Cachexia; Carrier Proteins; Cytokines; Double-Blind Method; Female; Fibrinogen; Humans; Infliximab; Intercellular Adhesion Molecule-1; Male; Membrane Glycoproteins; Middle Aged; Peroxidase; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Uteroglobin | 2008 |
8 other study(ies) available for fibrinogen and Cachexia
Article | Year |
---|---|
Increased thrombin generation in a mouse model of cancer cachexia is partially interleukin-6 dependent.
Topics: Animals; Blood Coagulation; Cachexia; Cell Line, Tumor; Disease Models, Animal; Fibrin; Fibrinogen; Gene Expression Regulation, Neoplastic; Humans; Inflammation; Interleukin-6; Liver; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasm Transplantation; Neoplasms; Thrombin; Tissue Array Analysis | 2017 |
Adipokines and systemic inflammation in weight-losing lung cancer patients.
Topics: Adiponectin; Aged; Aged, 80 and over; C-Reactive Protein; Cachexia; Carcinoma, Non-Small-Cell Lung; Ferritins; Fibrinogen; Humans; Leptin; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Platelet Count; Transferrin; Tumor Necrosis Factor-alpha | 2012 |
Fibrinogen synthesis is increased in cachectic patients with chronic heart failure.
Topics: Aged; Cachexia; Chronic Disease; Fibrinogen; Heart Failure; Humans; Male | 2008 |
The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo.
Topics: Analysis of Variance; Animals; Antibodies, Monoclonal; Blood Glucose; Cachexia; Disease Models, Animal; Escherichia coli; Fibrinogen; Hypoglycemia; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Inbred Strains; Triglycerides; Tumor Necrosis Factor-alpha; Weight Loss | 1993 |
Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response.
Topics: Acute-Phase Reaction; Adenocarcinoma; Adult; Aged; Amino Acids; C-Reactive Protein; Cachexia; Fasting; Female; Fibrinogen; Glycine; Humans; Kinetics; Male; Middle Aged; Muscle Proteins; Pancreatic Neoplasms; Reference Values; Serine; Tryptophan | 1998 |
The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction.
Topics: Animals; Blood Glucose; Cachexia; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Fibrinogen; Glycated Hemoglobin; Hepatomegaly; Hyperinsulinism; Islets of Langerhans; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Nicotinic Acids; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Risk Factors; Tetrahydronaphthalenes; Transcription Factors | 1999 |
Synthesis rates of albumin and fibrinogen in patients with cardiac and pulmonary cachexia.
Topics: Aged; Albumins; Cachexia; Female; Fibrinogen; Heart Failure; Humans; Liver; Lung Diseases; Male; Middle Aged | 1977 |
Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice.
Topics: Adenocarcinoma; Adipose Tissue; Animals; Body Weight; Cachexia; Catalase; Cell Line; Colonic Neoplasms; Cytochrome P-450 Enzyme System; Fibrinogen; Liver; Male; Mice; Mice, Inbred Strains; Neoplasm Proteins; Organ Size; Pentobarbital; Reference Values; Sialic Acids; Sleep; Time Factors; Weight Loss | 1990 |